January 2022 - CanadianCannabisWire

MondayJan 31, 2022 12:37 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Offers a Glimpse into Company’s Unique Technology and Operations on EDGE Podcast

Chris Bunka, the Chairman and CEO of Lexaria, featured on the EDGE podcast hosted by Brandon C. White He provided insight into his background, professional philosophies, and Lexaria’s operations, with a focus on the company’s patented DehydraTECH(TM) technology Mr. Bunka also advised small companies and entrepreneurs, citing the importance of understanding the competitive environment Chris Bunka, the Chairman and Chief Executive Officer (“CEO”) of Lexaria Bioscience (NASDAQ: LEXX), was recently featured on episode 234 of the EDGE Podcast. Hosted by Brandon C. White, an Angel Investor and Entrepreneur, Mr. Bunka shared insights into his professional journey while also sharing what…

FridayJan 28, 2022 10:00 am

Flora Growth Corp. (NASDAQ: FLGC) Names Cannabis Pioneer as Colombian Facility Advisor as Company Prepares for International Growth

Canada-based Flora Growth Corp. operates cannabis cultivation and extraction processes in-house at its Cosechemos lab and growth facility in central Colombia The company has been building a portfolio of cannabis and wellness products and obtaining a variety of licenses and GMP certifications as it establishes partnerships to economically distribute its portfolio worldwide Flora Growth recently announced the addition of pioneering cannabis genetics innovator Derek Pedro in an advisory role for its Cosechemos facility Pedro will help the company build on its more-than-190 product offerings with cannabis flower cultivation and distribution Cannabis cultivator and worldwide cannabidiol (“CBD”) brand builder Flora Growth…

ThursdayJan 27, 2022 11:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Emphasizes Oral Cannabinoid Delivery Benefits Following SARS-CoV-2 Study

The study is available for public viewing and is entitled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” (https://cnw.fm/Aq36i) Dr. Richard van Breeman, who headed the independent study, explained that smoking and vaping cannabinoids are ineffective against preventing SARS-CoV-2, whereas oral delivery methods are effective Lexaria has been studying and researching the oral delivery of compounds using its patented DehydraTECH(TM) technology, which enhances bioavailability and absorption, requiring less heat than smoking or vaping and leaving the cannabinoid compounds undamaged Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, commented on an independent January 10 study headed…

ThursdayJan 27, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Gains Full Cannabis Licensing to Rise in Michigan’s Developing Recreational Use Market

Multi-state cannabis operator Red White & Bloom Brands is developing opportunities strategically in sizable cannabis markets such as Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts The company recently announced it has secured full licensing for manufacturing both medical and adult use cannabis products in Michigan, one of its key markets Red White & Bloom has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in the state In Florida, Red White & Bloom settled a CAD$5.1 million debt at a favorable conversion price, granting the company an accounting gain of approximately CAD$2.3 million As Michigan…

WednesdayJan 26, 2022 12:15 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market

The global cannabinoid-based pharmaceuticals market is projected to be valued at $50 billion by 2029 InMed is leading the industry, laying down the foundation in manufacturing and clinical development of rare cannabinoids It is shedding light on the potential of rare cannabinoids and laying the groundwork on how to tap into the industry’s growth It is projected that by 2025, the global cannabis market will be valued at around $146 billion, up from just $20.47 billion in 2020. This sector is experiencing tremendous growth, particularly considering that there are over one hundred known cannabinoids, including rare ones that are quickly…

MondayJan 24, 2022 12:53 pm

Flora Growth Corp. (NASDAQ: FLGC) Kicks off 2022 with Successful First Cannabis Extraction at new Colombia Facility, the Appointment of Tim Leslie as Advisory Board Chairman, and 360 Financial Inc.’s FLGC stock purchase

Flora Growth just announced the production of its first batch of crude oil through its newly constructed facility in Colombia The company has also initiated the EU-GMP certification process that will allow it to target international medical cannabis markets Flora Growth also announced the appointment of Tim Leslie as Chairman of its newly established Advisory Board Mr. Leslie will play a key role in advising the company on how best to navigate the regulatory framework of building a truly global company 360 Financial, Inc. announced the purchase of 13,162 Flora Growth shares as of Q4 2021 Flora Growth (NASDAQ: FLGC)…

ThursdayJan 20, 2022 1:01 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Great Start to its 2022 R&D Programs Following Independent Review Board Approval

Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatment The stage is also set for other R&D programs for the 2022 calendar year, including HOR-A22-1, DEM-A22-1, RHEUM-A22-1 and DIAB-A22-1 All of these 2022 R&D programs are fully funded, with Lexaria having raised approximately $15 million over the 2021 calendar year Lexaria believes that these programs will build significant value for its stakeholders and pursue policies for substantial improvements to human health In late 2021, Lexaria Bioscience (NASDAQ: LEXX) announced several new and ongoing R&D programs for its patented DehydraTECH(TM) technology. While making the announcement,…

TuesdayJan 18, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in 2021, Year in Review

RWB marked 2021 with strategic acquisitions, with the most notable of them being Acreage Holdings Inc. and a 45,000 square foot greenhouse in Apopka, Florida These strategic investments would see the company steadily grow its revenue, marking a 93% year-over-year growth by Q3 The year also marked notable appointments, including Ryan Costello and Colby De Zen, both into the company’s Board of Directors RWB is confident that the foundations laid down in 2021 will play a vital role in the company’s growth in 2022, as well as creating shareholder value Since its inception, Red White & Bloom Brands (CSE: RWB)…

FridayJan 14, 2022 9:00 am

After a Successful 2021, Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off 2022 With New Media Strategy, Plans for Clinical Study Advancements

Lexaria has multiple studies planned that will commence early in 2022 DehydraTECH increases Lexaria’s ability to leverage multiple markets, including the growing CBD sector, which is expected to meet and exceed $108 billion in revenue by 2027 DehydraTECH can increase the efficacy of the drugs being administered, offering faster absorption and lowering the delivery time In a strategic move to start off 2022, Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that it has signed an advertising and media contract with financial technology company SRAX (NASDAQ: SRAX). The contract will facilitate media buys and digital…

ThursdayJan 13, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Targeting Increased Revenue and Margins with Strategic Focus on Vertical Integration

RWB recently reported its Q3 2021 financial results in which revenues grew 93% YOY The company is pursuing vertical integration in multiple states, including Florida, California, and Michigan In Florida, RWB has launched cultivation operations and a processing facility expected to provide additional inventory for its Springhill dispensary, as well as three new dispensaries set to be opened in Q1 2022 According to RWB Chairman and CEO Brad Rogers, vertical integration will help drive increased revenue and margins for the company In the third quarter of fiscal 2021, multistate cannabis operator and house of premium brands Red White & Bloom…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977

Month: January 2022